Summary of Study ST003204

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001988. The data can be accessed directly via it's Project DOI: 10.21228/M8RJ07 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003204
Study TitleGlutamine Tracing Assay on Caki1 WT and 769P WT versus Caki1 RquA and 769P RquA
Study SummaryThe extraction of Caki1 and 769P cell types in the condition WT versus RquA and in 21% O2 versus 0.5% O2 for 13C5 Glutamine Tracing Assay.
Institute
UMass Chan Medical School
Last NameUMass Chan
First NameSpinelli Lab
Address55 Lake Avenue North, Worcester, Massachusetts, 01605, USA
Emailspinellilab@gmail.com
Phone(508) 856-8989 ext. 68148
Submit Date2024-05-08
Raw Data AvailableYes
Raw Data File Type(s)mzML, raw(Thermo)
Analysis Type DetailLC-MS
Release Date2025-02-04
Release Version1
Spinelli Lab UMass Chan Spinelli Lab UMass Chan
https://dx.doi.org/10.21228/M8RJ07
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001988
Project DOI:doi: 10.21228/M8RJ07
Project Title:Rhodoquinone is an Electron Carrier in the Mammalian Electron Transport Chain
Project Summary:Ubiquinone (UQ), the only known electron carrier in the mammalian electron transport chain (ETC), delivers electrons to both oxygen (O2) and fumarate as terminal electron acceptors. As fumarate has a lower reduction potential than UQ, fumarate reduction is only thermodynamically favorable when ubiquinol, the reduced form of UQ, accumulates. Paradoxically, some tissues reduce fumarate without ubiquinol buildup, suggesting another mechanism enables fumarate reduction in mammals. Here, we identify rhodoquinone (RQ), a novel mammalian electron carrier that directs electrons to fumarate, instead of O2, as the favored terminal electron acceptor. RQ, which is undetectable in cultured mammalian cells, is enriched in tissues that catalyze fumarate reduction. RQ and UQ-directed ETC circuits support distinct programs of mitochondrial function. Through expression of a bacterial enzyme that converts UQ into RQ and development a novel RQ analog, we demonstrate that reprogramming the mammalian ETC from the UQ to RQ circuit renders cells highly resistant to hypoxia exposure. Thus, we establish RQ as a fundamental component of the mammalian ETC and unveil reprogramming the ETC to the RQ-circuit as a tractable strategy to treat hypoxia-related diseases.
Institute:UMass Chan Medical School
Department:Program in Molecular Medicine
Laboratory:Spinelli Lab
Last Name:UMass Chan
First Name:Spinelli Lab
Address:55 Lake Avenue North, Worcester, Massachusetts, 01605, USA
Email:spinellilab@gmail.com
Phone:(508) 856-8989 ext. 68148

Subject:

Subject ID:SU003323
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606
Species Group:Mammals

Factors:

Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Sample source Treatment
SA348784RQUA 769P 0.5% 1Human Renal 769P Cells RquA 0.5% O2
SA348785RQUA 769P 0.5% 2Human Renal 769P Cells RquA 0.5% O2
SA348786RQUA 769P 0.5% 3Human Renal 769P Cells RquA 0.5% O2
SA348787RQUA 769P 21% 2Human Renal 769P Cells RquA 21% O2
SA348788RQUA 769P 21% 1Human Renal 769P Cells RquA 21% O2
SA348789RQUA 769P 21% 3Human Renal 769P Cells RquA 21% O2
SA348790WT 769P 0.5% 3Human Renal 769P Cells WT 0.5% O2
SA348791WT 769P 0.5% 1Human Renal 769P Cells WT 0.5% O2
SA348792WT 769P 0.5% 2Human Renal 769P Cells WT 0.5% O2
SA348793WT 769P 21% 3Human Renal 769P Cells WT 21% O2
SA348794WT 769P 21% 2Human Renal 769P Cells WT 21% O2
SA348795WT 769P 21% 1Human Renal 769P Cells WT 21% O2
SA348796RQUA CAKI 1 0.5% 1Human Renal Caki1 Cells RquA 0.5% O2
SA348797RQUA CAKI 1 0.5% 2Human Renal Caki1 Cells RquA 0.5% O2
SA348798RQUA CAKI 1 0.5% 3Human Renal Caki1 Cells RquA 0.5% O2
SA348799RQUA CAKI 1 21% 2Human Renal Caki1 Cells RquA 21% O2
SA348800RQUA CAKI 1 21% 1Human Renal Caki1 Cells RquA 21% O2
SA348801RQUA CAKI 1 21% 3Human Renal Caki1 Cells RquA 21% O2
SA348802WT CAKI 1 0.5% 2Human Renal Caki1 Cells WT 0.5% O2
SA348803WT CAKI 1 0.5% 1Human Renal Caki1 Cells WT 0.5% O2
SA348804WT CAKI 1 0.5% 3Human Renal Caki1 Cells WT 0.5% O2
SA348805WT CAKI 1 21% 2Human Renal Caki1 Cells WT 21% O2
SA348806WT CAKI 1 21% 3Human Renal Caki1 Cells WT 21% O2
SA348807WT CAKI 1 21% 1Human Renal Caki1 Cells WT 21% O2
Showing results 1 to 24 of 24

Collection:

Collection ID:CO003316
Collection Summary:Human Renal Caki-1 Cells and Human Renal 769P Cells were purchased from ATCC and cultured in complete DMEM media. When the cells were collected the media was aspirated from the plates and then the cells were washed with 1x PBS (Phosphate Buffered Saline) twice to wash the cells of old media. The plate was then transferred to dry ice and 500 µL of 80% HPLC-grade methanol (Sigma) 20% HPLC-grade water (Sigma) was added to each well. The wells were placed in a -80 freezer to incubate for 15 minutes. The plates are taken out of the freezer one at a time and placed back on dry ice. The cells were then scraped and transferred to a new tube. Each well was washed with an additional 300 µL of 80% HPLC-grade methanol (Sigma) 20% HPLC-grade water (Sigma) and collected into the same tube as the initial lysis. The samples were then vortexed at 4° C for 10 minutes and centrifuged at 21,300 x g for 10 minutes at 4° C. Supernatants were transferred to a new tube and dried down in a Refrigerated CentriVap Benchtop Vacuum Concentrator connected to a CentriVap-105 Cold Trap (Labconco). After being dried down, pellets were stored in a -20° C freezer until ready to run on the polar LC-MS method.
Sample Type:Cultured cells

Treatment:

Treatment ID:TR003332
Treatment Summary:Cells were seeded in complete DMEM 5 days prior to tracing so that wells reached 75% confluence at the time of the experiment. After seeding, cells were treated with their respective conditions (WT versus RquA) and incubated in 21% O2 or 0.5% O2 for seven days. For experiments involving the hypoxia chamber (0.5% O2), media were preconditioned at 0.5% O2 for 72 hours prior to use for experiments. Tracing media was then prepared, with glutamine-free DMEM (Gibco) containing 10% Fetal Bovine Serum (FBS), 1% PenStrep, and 0.1 mg/mL uridine supplemented with 2 mM 13C515N2-glutamine (Cambridge Isotope Labs). Media was refreshed in each well with stable isotope tracing media and incubated for 8 hours.

Sample Preparation:

Sampleprep ID:SP003330
Sampleprep Summary:The pellet was resuspended in 200uL of LCMS H2O (Sigma), vortexed for 10 minutes in 4°C, centrifuged for 10 minutes at 21,300 x g at 4°C, and then moved 20uL into LCMS vials to run on the LCMS.

Chromatography:

Chromatography ID:CH003978
Instrument Name:Thermo Vanquish
Column Name:Merck SeQuant ZIC-HILIC (150 x 2.1mm,5um)
Column Temperature:25
Flow Gradient:20 min, 80% - 20% B; 0.5 min, 20% - 80% B; 7.5min, 80% B
Flow Rate:0.15ml/min
Solvent A:100% water; 0.1% ammonium hydroxide; 20mM ammonium carbonate
Solvent B:100% acetonitrile
Chromatography Type:HILIC

Analysis:

Analysis ID:AN005255
Analysis Type:MS
Chromatography ID:CH003978
Num Factors:8
Num Metabolites:126
Rt Units:Minutes
Units:peak area
  
Analysis ID:AN005256
Analysis Type:MS
Chromatography ID:CH003978
Num Factors:8
Num Metabolites:244
Rt Units:Minutes
Units:peak area
  logo